Published in J Immunol on April 01, 1991
Effects of cyclosporin A and FK506 on Fc epsilon receptor type I-initiated increases in cytokine mRNA in mouse bone marrow-derived progenitor mast cells: resistance to FK506 is associated with a deficiency in FK506-binding protein FKBP12. Proc Natl Acad Sci U S A (1992) 1.11
The spectrum of action of new immunosuppressive drugs. Clin Exp Immunol (1992) 0.87
FK 506 and autoimmune disease: perspective and prospects. Autoimmunity (1992) 0.85
Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506. Br J Pharmacol (2007) 0.82
Rapamycin but not FK506 inhibits the proliferation of mononuclear phagocytes induced by colony-stimulating factors. Transplantation (1994) 0.81
Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophils. Eur J Clin Pharmacol (1993) 0.77
The effect of the immunophilin ligands rapamycin and FK506 on proliferation of mast cells and other hematopoietic cell lines. Mol Biol Cell (1992) 0.77
Future modalities. Arch Dermatol Res (1992) 0.75
Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res (2001) 4.87
Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J Biol Chem (1993) 2.38
Divergent effects of serotonin on coronary-artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. N Engl J Med (1991) 2.06
Diastolic perfusion time at ischemic threshold in patients with stress-induced ischemia. Circulation (1991) 1.97
A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. Eur Respir J (1993) 1.84
Local effect of serotonin released during coronary angioplasty. N Engl J Med (1994) 1.81
Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke (2001) 1.66
Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1. Eur Heart J (2001) 1.62
Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis. J Clin Invest (2001) 1.59
New-onset angina preceding acute myocardial infarction is associated with improved contractile recovery after thrombolysis. Eur Heart J (1998) 1.54
In vitro effects of ultraviolet A on histamine release from human basophils. J Eur Acad Dermatol Venereol (2003) 1.40
In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. Minerva Cardioangiol (2011) 1.39
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. Am J Pathol (1999) 1.33
Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation (1998) 1.33
Maternal hypercholesterolemia and treatment during pregnancy influence the long-term progression of atherosclerosis in offspring of rabbits. Circ Res (2001) 1.30
Allergy and the cardiovascular system. Clin Exp Immunol (2008) 1.27
Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAF. Eur J Pharmacol (1989) 1.21
Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis (1988) 1.21
Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest (1991) 1.20
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J Immunol (1980) 1.19
Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol (1995) 1.17
Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy (2010) 1.17
Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab (2006) 1.17
Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. J Immunol (1979) 1.17
The heart: an end-organ of GH action. Eur J Endocrinol (2004) 1.16
Ultrasound-guided percutaneous treatment of hepatocellular carcinoma by radiofrequency hyperthermia with a 'cooled-tip needle'. A preliminary clinical experience. Eur J Ultrasound (1999) 1.14
HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol (2000) 1.11
Adenosine receptor on human basophils: modulation of histamine release. J Immunol (1979) 1.11
Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension. Am Heart J (2004) 1.10
Characterization of a specific adenosine receptor on human lymphocytes. J Immunol (1978) 1.10
Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice. Proc Natl Acad Sci U S A (2001) 1.09
Asymptomatic transient ST changes during ambulatory ECG monitoring in diabetic patients. Am Heart J (1985) 1.09
Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation (1986) 1.09
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages. J Immunol (2000) 1.08
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J Exp Med (1995) 1.06
Hemobilia, intrahepatic hematoma and acute thrombosis with cavernomatous transformation of the portal vein after percutaneous thermoablation of a liver metastasis. Eur Radiol (2000) 1.04
The role of estrogen in the regulation of erythropoietin production. Endocrinology (1973) 1.04
The role of basophils and mast cells in the pathogenesis of pulmonary diseases. Int Arch Allergy Appl Immunol (1985) 1.03
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. J Clin Invest (1994) 1.03
Recombinant human, active site-blocked factor VIIa reduces infarct size and no-reflow phenomenon in rabbits. Am J Physiol Heart Circ Physiol (2000) 1.02
The mechanism of basophil histamine release induced by pepstatin A. J Immunol (1984) 1.02
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. Mol Pharmacol (1998) 1.00
Expression of the chemokine receptor CCR3 on human mast cells. Int Arch Allergy Immunol (2001) 1.00
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med (1996) 0.99
Transesophageal pacing for prognostic evaluation of preexcitation syndrome and assessment of protective therapy. Am J Cardiol (1983) 0.98
Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma. Hepatology (2001) 0.98
Effects of converting enzyme inhibition on heart period variability in patients with acute myocardial infarction. Circulation (1994) 0.97
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol (1990) 0.97
Histamine induces exocytosis and IL-6 production from human lung macrophages through interaction with H1 receptors. J Immunol (2001) 0.97
Globin chain synthesis in single erythroid bursts from cord blood: studies on gamma leads to beta and G gamma leads to A gamma switches. Proc Natl Acad Sci U S A (1980) 0.97
Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer (2001) 0.97
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. J Immunol (1994) 0.96
Mast cells have a protumorigenic role in human thyroid cancer. Oncogene (2010) 0.96
Protective effects of simultaneous alpha and beta adrenergic receptor blockade on myocardial cell necrosis after coronary arterial occlusion in rats. Am J Cardiol (1980) 0.96
Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig (1993) 0.95
Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion. J Pharmacol Exp Ther (1987) 0.95
Evidence for an adenosine A2/Ra receptor on human basophils. Life Sci (1985) 0.95
Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol (1999) 0.94
Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc. J Pharmacol Exp Ther (1981) 0.94
IgE-mediated histamine release from human basophils: differences between antigen E- and anti-IgE-induced secretion. Int Arch Allergy Appl Immunol (1981) 0.94
Severity of coronary artery disease in patients with diabetes mellitus. Angiographic study of 34 diabetic and 120 nondiabetic patients. Am Heart J (1980) 0.94
Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer. Br J Cancer (2001) 0.94
Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. J Allergy Clin Immunol (1987) 0.93
Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty. Circulation (1995) 0.93
Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect Immun (2000) 0.93
Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma. J Clin Endocrinol Metab (2000) 0.93
Cardiovascular effects of histamine infusion in man. J Cardiovasc Pharmacol (1983) 0.92
[Research on the antigenic properties of renin. 3. Behavior of the precipitation reaction in agar between anti-renin immune serums and renal extracts with renin activity subjected to inactivation procedures. Study of the relations between neutralizing power and precipitating activity of antirenin immune serums]. Boll Soc Ital Biol Sper (1967) 0.92
Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology (1988) 0.92
Hemodynamic response to exercise after propranolol in patients with mitral stenosis. Am J Cardiol (1979) 0.91
Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis (1996) 0.91
Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol (1992) 0.91
Possible role of calmodulin in human inflammatory reactions. Monogr Allergy (1983) 0.90
Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats. Eur J Pharmacol (1996) 0.90
Characterization of the anti-inflammatory effect of FK-506 on human mast cells. J Immunol (1991) 0.90
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. Anesthesiology (1992) 0.90
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum (1996) 0.89
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J Allergy Clin Immunol (1996) 0.89
Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro. Clin Immunol Immunopathol (1981) 0.89
Effects of histamine on coronary hemodynamics in humans: role of H1 and H2 receptors. J Am Coll Cardiol (1987) 0.89
Evaluation of the efficacy of slow-release nifedipine in systemic hypertension by ambulatory intraarterial blood pressure monitoring. J Cardiovasc Pharmacol (1985) 0.89
Eosinophil granule proteins activate human heart mast cells. J Immunol (1996) 0.89
Tat protein is an HIV-1-encoded beta-chemokine homolog that promotes migration and up-regulates CCR3 expression on human Fc epsilon RI+ cells. J Immunol (2000) 0.88
Davos declaration: allergy as a global problem. Allergy (2012) 0.88